Tolrestat (INN; AY-27773) is an aldose reductase inhibitor which was approved for the control of certain diabetic complications.
via PubMed
{{Drugbox | Verifiedfields = changed | verifiedrevid = 408940699 | IUPAC_name = N-{[6-methoxy-5-(trifluoromethyl)-1-naphthyl]carbothioyl}-N-methylglycine | image = Tolrestat structure.svg | image_class = skin-invert-image | alt = Skeletal formula of tolrestat | image2 = Tolrestat 3D ball.png | alt2 = Ball-and-stick model of the tolrestat molecule | image_class2 = bg-transparent
| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Withdrawn from market | routes_of_administration =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).